AI Biomed PredictionsOBIO – HRS AVIM data could spark OBIO’s next revaluation ScanScor Admin / May 2, 2026
AI Biomed PredictionsINO – Depressed Inovio May Rebound on FDA Review Reassurance ScanScor Admin / May 2, 2026
AI Biomed PredictionsADAG – Next ADAG move likely hinges on execution, not hype ScanScor Admin / May 2, 2026
AI Biomed PredictionsACXP – Microcap ACXP hinges on proof ibezapolstat development is truly starting ScanScor Admin / May 2, 2026
AI Biomed PredictionsGANX – GANX Faces a Crucial May Test for Parkinson’s Repricing ScanScor Admin / May 2, 2026
AI Biomed PredictionsMGNX – Mid-2026 data could decide MacroGenics’ turnaround trajectory ScanScor Admin / May 2, 2026
AI Biomed PredictionsOKUR – Cash-Rich OnKure Awaits Fall Data Validation for PI3K Thesis ScanScor Admin / May 2, 2026
AI Biomed PredictionsNRSN – May regulatory clarity could decide NeuroSense’s next ALS breakout ScanScor Admin / May 2, 2026
AI Biomed PredictionsTRAW – MHRA decision could reawaken Traws’ deeply discounted antiviral story ScanScor Admin / April 30, 2026
AI Biomed PredictionsRNAZ – Phase 2a clearance may decide RNAZ’s next sharp move ScanScor Admin / April 30, 2026
